ADHerence of Ticagrelor in Real-World Patients with Acute Coronary Syndrome: The AD-HOC Study

Author:

Fiocca Luigi,Rossini Roberta,Carioli Greta,Carobbio Alessandra,Piazza Isabelle,Collaku Elona,Giubilato Simona,Amico Francesco,Molfese Maria,De Benedictis Mauro,Calabria Paolo,Limbruno Ugo,Valente Serafina,Ferlini Marco,Spezzano Tiziana,Senni Michele,Gavazzi Antonello

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference26 articles.

1. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;M Valgimigli;Eur Heart J,2017

2. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;J-P Collet;Eur Heart J,2020

3. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction;M P Bonaca;New Eng J Med,2015

4. Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation;I Ferreira-Gonz�lez;J Am Heart Assoc,2010

5. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation;R Rossini;Am J Cardiol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3